All Programs

Use the tool below to view all available Series

Double-Class Refractory CLL in Community Practice: Current and Future Management
Double-Class Refractory CLL in Community Practice: Current and Future Management
CME/CE
Double-Class Refractory CLL in Community Practice: Current and Future Management
John C. Byrd, MD; William Mencia, MD, FACEHP
0.25 credits
- John C. Byrd, MD
- William Mencia, MD, FACEHP
0.25 credits
Navigating Treatment Sequencing After Frontline Treatment Failure in CLL
Navigating Treatment Sequencing After Frontline Treatment Failure in CLL
CME/CE
Navigating Treatment Sequencing After Frontline Treatment Failure in CLL
Jennifer R. Brown, MD, PhD; William Mencia, MD, FACEHP
0.25 credits
- Jennifer R. Brown, MD, PhD
- William Mencia, MD, FACEHP
0.25 credits
CME/CE In-Person Event
Moving Beyond Sleep: The Broader Connection Between the Orexin System and Psychiatric Disorders
May 27, 2026
Miami Beach, Florida
1.00 credit
Treat-to-Target: Are We There Yet? 
Treat-to-Target: Are We There Yet? 
MinuteCE®
Treat-to-Target: Are We There Yet? 
Kimberly D. Orleck, PA-C; Jennifer Geremia, PA-C
1.00 program credit
- Kimberly D. Orleck, PA-C
- Jennifer Geremia, PA-C
1.00 program credit
Severity Assessment: Can You Pin the Stage on the Patient?
Severity Assessment: Can You Pin the Stage on the Patient?
MinuteCE®
Severity Assessment: Can You Pin the Stage on the Patient?
Jennifer Geremia, PA-C; Brooke Hodnick, PA-C, MPAS
1.00 program credit
- Jennifer Geremia, PA-C
- Brooke Hodnick, PA-C, MPAS
1.00 program credit
Tailoring Treatment: Can You Select the Best Therapy? 
Tailoring Treatment: Can You Select the Best Therapy? 
MinuteCE®
Tailoring Treatment: Can You Select the Best Therapy? 
David Rubin, MD; Brooke Hodnick, PA-C, MPAS
1.00 program credit
- David Rubin, MD
- Brooke Hodnick, PA-C, MPAS
1.00 program credit
MinuteCE®
From Flare to Farewell: The IBD Care Playbook for Advanced Practice Providers
David Rubin, MD; Kimberly D. Orleck, PA-C
1.00 credit 9 episodes
- David Rubin, MD
- Kimberly D. Orleck, PA-C
- Jennifer Geremia, PA-C
- Brooke Hodnick, PA-C, MPAS
1.00 credit 9 episodes
Treatment of Hepatic Encephalopathy: Primary vs Secondary Prophylaxis
Treatment of Hepatic Encephalopathy: Primary vs Secondary Prophylaxis
MinuteCE®
Treatment of Hepatic Encephalopathy: Primary vs Secondary Prophylaxis
Arun B. Jesudian, MD; Nancy S. Reau, MD
1.00 program credit
- Arun B. Jesudian, MD
- Nancy S. Reau, MD
1.00 program credit
Treatment of Hepatic Encephalopathy: When, What, How, and Why?
Treatment of Hepatic Encephalopathy: When, What, How, and Why?
MinuteCE®
Treatment of Hepatic Encephalopathy: When, What, How, and Why?
Arun B. Jesudian, MD
1.00 program credit
- Arun B. Jesudian, MD
1.00 program credit
Advances in the Treatment of Overt Hepatic Encephalopathy: What's in the Pipeline?
Advances in the Treatment of Overt Hepatic Encephalopathy: What's in the Pipeline?
MinuteCE®
Advances in the Treatment of Overt Hepatic Encephalopathy: What's in the Pipeline?
Arun B. Jesudian, MD; Nancy S. Reau, MD
1.00 program credit
- Arun B. Jesudian, MD
- Nancy S. Reau, MD
1.00 program credit
Hepatic Encephalopathy: More Common Than You Think
Hepatic Encephalopathy: More Common Than You Think
MinuteCE®
Hepatic Encephalopathy: More Common Than You Think
Arun B. Jesudian, MD
1.00 program credit
- Arun B. Jesudian, MD
1.00 program credit
Current Treatment of Hepatic Encephalopathy: Is It Meeting Our Patients' Needs?
Current Treatment of Hepatic Encephalopathy: Is It Meeting Our Patients' Needs?
MinuteCE®
Current Treatment of Hepatic Encephalopathy: Is It Meeting Our Patients' Needs?
Arun B. Jesudian, MD
1.00 program credit
- Arun B. Jesudian, MD
1.00 program credit
Minimal Hepatic Encephalopathy: Hiding in Plain Sight?
Minimal Hepatic Encephalopathy: Hiding in Plain Sight?
MinuteCE®
Minimal Hepatic Encephalopathy: Hiding in Plain Sight?
Arun B. Jesudian, MD; Nancy S. Reau, MD
1.00 program credit
- Arun B. Jesudian, MD
- Nancy S. Reau, MD
1.00 program credit
Precision Treatment Pathways for MDD and Comorbid Insomnia
Precision Treatment Pathways for MDD and Comorbid Insomnia
CME/CE
Precision Treatment Pathways for MDD and Comorbid Insomnia
Michael E. Thase, MD
0.25 credits
- Michael E. Thase, MD
0.25 credits
Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia
Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia
CME/CE
Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia
Christoph U. Correll, MD; Jonathan M. Meyer
0.25 credits
- Christoph U. Correll, MD
- Jonathan M. Meyer
0.25 credits
Guideline Recommendations in First-Line Treatment of HER2-Negative Upper GI Cancers
Guideline Recommendations in First-Line Treatment of HER2-Negative Upper GI Cancers
MinuteCE®
Guideline Recommendations in First-Line Treatment of HER2-Negative Upper GI Cancers
James M. Cleary, MD, PhD
0.50 program credits
- James M. Cleary, MD, PhD
0.50 program credits

All Programs

Popular

Title